Issue link: https://beckershealthcare.uberflip.com/i/772947
34 PRACTICE MANAGEMENT Resurgens Orthopaedics Opens 7th ASC By Laura Dyrda A tlanta-based Resurgens Orthopaedics opened its seventh surgery center in Covington, Ga. Here are five things to know about the new surgery center: 1. Stephenson Ikpe Jr., MD, was hired to practice at the new center, called Resurgens East Surgery Center. Addi- tional physicians who are joining the center include Jane S. Tan, MD, Roderica E. Cottrell, MD, Robert T. Greenfield, MD, and Chealon D. Miller, MD. 2. The surgery center will include general orthopedics, arthroscopic knee and shoulder reconstruction, knee and shoulder surgery and sports medicine. 3. Emory Anesthesia will provide anesthesia for the center. 4. As the seventh Resurgens surgery center, the facility rounds out Resurgens' footprint in the metropolitan At- lanta area. Resurgens has 21 physician offices and 97 af- filiated physicians. 5. In September, the practice added two orthopedic sur- geons to the southwest region offices in preparation for an expansion in that region early next year. The surgeons have expertise in minimally invasive joint replacement and upper extremity surgery. n Top 10 Highest-Earning Physician Specialties By Anuja Vaidya F or the last six years in a row, orthopedics has been the highest-paid specialty in the country, and this year is no different, according to the Medscape Physician Compen- sation Report 2016. In that time, orthopedic surgeon salary has increased from $350,000 in 2010 to $443,000 in 2016. Here are the 10 top-earning specialties, according to Med- scape: • Orthopedics — $443,000 • Cardiology — $410,000 • Dermatology — $381,000 • Gastroenterology — $380,000 • Radiology — $375,000 • Urology — $367,000 • Anesthesiology — $360,000 • Plastic surgery — $355,000 • Oncology — $329,000 • General surgery — $322,000 Note: Nearly 19,200 physicians in over 26 specialties respond- ed to the survey. n What Stryker CEO Kevin Lobo said on CNBC: 7 Key Quotes By Laura Dyrda Kalamazoo, Mich.-based Stryker CEO Kevin Lobo appeared on CNBC's Squawk CEO Call to discuss several aspects of the business and where his company is headed in the future. e discussion touched on: 1. e medical device excise tax, which Mr. Lobo called a job and inno- vation killer. "We look forward to, with the new administration, a full repeal, which has been talked about." 2. How the ACA did and didn't impact Stryker. "Even with ACA, new people insured, we didn't see a bump in our volumes. Regardless of what happens with the new administration, we aren't expecting any change." 3. Historic and future projections for sales volumes and organic growth. "Our volumes have been very consistent, very steady. Our organic growth, we've had 14 quarters in a row growing higher than 5 percent and unlike pharmaceuticals, our medical device products prices have been declining every year since 2008. Our price decrease each year is 1.5 to 2 percent." 4. Operating in several healthcare systems around the world. "We operate in all types of healthcare systems around the world. Single payer systems in France or Canada, two tier systems in the U.K., and we are able to grow our business around the world. As long as our products are inno- vative they add value to the healthcare system, we are going to continue to grow." 5. e potential for corporate tax reform. "Macroeconomic policies, cor- porate tax reform would be fabulous. We are below 20 percent, we have a low effective rate, but what we really like is having the ability to pull back our U.S. cash." 6. Recent acquisitions. "Having that flexibility for cash, we have been ac- quisitive. We've done over 40 deals in the last four years and spent over $4 billion in the first quarter of this year and bringing that cash back gives us a lot of flexibility to continue doing more acquisitions and do more investment. But it puts us on a level playing field with competitors that have done inversions. We've stayed in the U.S. so having that trapped cash gives me more flexibility. Today, I have to borrow every time, event to pay a dividend I have to borrow money." 7. Capital allocations. "For us, our capital allocation favors acquisitions first, then dividends and buy backs, but it gives us tremendous flexibility to do all three of those." n